Latest Ptsd News

Page 4 of 4
Emyria reports sustained and statistically significant improvements in PTSD symptoms and quality of life three months after MDMA-assisted therapy, signaling a potential breakthrough for treatment-resistant patients.
Ada Torres
Ada Torres
4 Feb 2025
Emyria Limited reports strong progress in its MDMA and psilocybin-assisted therapy programs alongside a successful $2.525 million capital raise, positioning the company for expanded mental health treatment services.
Ada Torres
Ada Torres
31 Jan 2025
Emyria Limited announces key leadership shifts with Greg Hutchinson stepping up as Executive Chairman and Dr. Michael Winlo transitioning to Chief Scientific Officer, aiming to scale innovative mental health therapies amid growing demand.
Ada Torres
Ada Torres
22 Jan 2025

Browse the archive

Full archive